Publicacións nas que colabora con Antonio Pérez Martínez (9)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

2021

  1. The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 23, Núm. 12, pp. 2489-2496

2018

  1. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients

    Breast Cancer Research and Treatment, Vol. 167, Núm. 1, pp. 249-256

2017

  1. Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer

    Pharmacogenetics and Genomics, Vol. 27, Núm. 12, pp. 445-453

  2. Memory T cells expressing an NKG2D-CAR efficiently target osteosarcoma cells

    Clinical Cancer Research, Vol. 23, Núm. 19, pp. 5824-5835

2016

  1. Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome

    Annals of Oncology, Vol. 27, Núm. 9, pp. 1788-1793

2015

  1. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner

    Cancer Letters, Vol. 368, Núm. 1, pp. 54-63

2011

  1. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: A pharmacogenetic study

    PLoS ONE, Vol. 6, Núm. 10